Lakefront Biotherapeutics
LKFTBiotechnology
$32.33+0.78%As of Oct 29vs prior close
- Market cap
- $2.1B
- From 52W high
- −6.67%
- EPS (YE25)
- €4.87
- Revenue (YE25)
- €1.1B
- Net margin
- 28.85%
- Dividend yield
- 0.00%
Nomior Score
50
Steady ProfileBottom 50% of the scored universe
Growth—
Quality66
Value—
Momentum31
Resilience56
Growth
+26.99%revenue a year over 9 fiscal years
YE16 €129.5MYE25 €1.1B
Connections
Revenue to profitYE25
29% of revenue became net profit, up 2 pts on a year.
Who owns it
1tracked portfolio